Selective cell dissemination into the heart by retrograde intracoronary infusion in the rat.

Cell transplantation through the intracoronary route has theoretical advantages over direct intramuscular injection in global cell dissemination into the myocardium with less injury. The authors have established a novel experimental model of retrograde intracoronary infusion in the rat by which the feasibility of this infusion for cell transplantation and the dynamics of myoblasts grafted by this route were investigated. After retrograde intracoronary implantation of beta-galactosidase-expressing myoblasts, myoblasts were observed to disseminate to all layers of only the left ventricular free wall, with little myocardial damage, and to differentiate into multinuclear myotubes by day 28. Beta-galactosidase enzyme activity estimated that 31.4% of initially grafted myoblasts existed within the heart at 10 min after implantation. The number slightly increased by day 3, increased to 117.3% at day 7, and reached a plateau of 132.1% at day 14. These data suggest the utility of retrograde intracoronary infusion for selective cell dissemination into the myocardium.

[1]  E. Audinat,et al.  Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Wernet,et al.  Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in Humans , 2002, Circulation.

[3]  M. Yacoub,et al.  Intracoronary Infusion of Skeletal Myoblasts Improves Cardiac Function in Doxorubicin-Induced Heart Failure , 2001, Circulation.

[4]  A. Hagège,et al.  Myoblast transplantation for heart failure , 2001, The Lancet.

[5]  M. Yacoub,et al.  Development of a Novel Method for Cell Transplantation Through the Coronary Artery , 2000, Circulation.

[6]  C. Murry,et al.  Electromechanical coupling between skeletal and cardiac muscle. Implications for infarct repair. , 2000 .

[7]  T. Partridge,et al.  Dynamics of Myoblast Transplantation Reveal a Discrete Minority of Precursors with Stem Cell–like Properties as the Myogenic Source , 1999, The Journal of cell biology.

[8]  R. Hruban,et al.  Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: long-term survival and phenotypic modification of implanted myoblasts. , 1996, Cell transplantation.

[9]  M. Noble,et al.  Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. , 1994, Developmental biology.